The significance of Streptococcus agalactiae as an aetiological agent in vaginitis was evaluated. A total of 6226 samples from women who presented with vaginal symptoms was examined. The presence of >10 leucocytes/high-power field (h.p.f.) was taken to be the criterion of active infection. S. agalactiae was isolated from 10.1% of these samples. The isolation rates of other common pathogens such as Candida spp., Gardnerella vaginalis and Trichomonas spp. were 54.1%, 27.2% and 4.2%, respectively, in the same group of patients. In contrast, the isolation rates of these micro-organisms in the group of patients who had no infection (< 10 leucocytes/h.p.f.) were 4.2%, 38.3%, 33% and 0.5%, respectively. In the majority of samples from which S. agalactiae was isolated, it was the sole pathogen isolated (83%) and its presence was associated with an inflammatory response in 80% of patients. Furthermore, the relative risk of vaginal infection with S. agalactiae (2.38) in patients with purulent vaginal discharge was greater than that of Candida spp. infection (1.41) and lower than that of Trichomonas spp. infection (8.32). These data suggest that S. agalactiae in symptomatic women with microscopic evidence of inflammation should be considered a causative agent of vaginitis.
ReganJ. A.,
ChaS.,
JamesL. S. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol1981; 141:184–186
BoyerK. M.,
GadzalaC. A.,
KellyP. D.,
BurdL. I.,
GotoffS. P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis1983; 148:802–809
SchwartzB.,
SchuchatA.,
OxtobyM. J.,
CochiS. L.,
HightowerA.,
BroomeC. V. Invasive group B streptococcal diseases in adults. A population-based study in metropolitan Atlanta. JAMA1991; 266:1112–1114
FarleyM. M.,
HarveyR. C.,
StullT. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med1993; 328:1807–1811
EdwardsM. S.,
BakerC. J.Streptococcus agalactiae (group B streptococcus). In
MandellG. L.,
DouglasR. G.,
BennetJ. E.
(eds) Principles and practice in infectious diseases 3rd edn New York: Churchill Livingstone; 19901554–1563
EidelmanA. I.,
RudenskyB.,
TurgemanD.,
NubaniN.,
SchimmelM. S.,
IsacsohnM. Epidemiology of group B streptococci colonization and disease in mothers and infants: update of ongoing 10-year Jerusalem study. Isr J Med Sci1990; 26:71–73
ViscontiA.,
OreficiG.,
NotamicolaA. M. Colonization and infection of mothers and neonates with group B streptococci in three Italian hospitals. J Hosp Infect1985; 6:265–276
EasmonC. S.,
HastingsJ. G. M.,
NeillJ.,
BloxhamB.,
RiversR. P. A. Is group B streptococcal screening during pregnancy justified?. Br J Obstet Gynaecol1985; 92:197–201
AnthonyB. F.,
EisenstadtR.,
CarterJ.,
KimK. S.,
HobelC. J. Genital and intestinal carriage of Group B streptococci during pregnancy. J Infect Dis1981; 143:761–766
KontnickC. M.,
EdbergS. C. Direct detection of group B streptococci from vaginal specimens compared with quantitative culture. J Clin Microbiol1990; 28:336–339
GardnerS. E.,
YowM. D.,
LeedsL. J.,
ThompsonP. K.,
MasonE. O.,
ClarkD. J. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol1979; 135:1062–1065
TsakrisA.,
ManiatisA. N. Inducible type of erythromycin resistance among group B streptococci isolated in Greece. J Antimicrob Chemother1993; 31:177–178
AronoffS. C.,
LaurentC.,
JacobsM. R. In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens. J Antimicrob Chemother1987; 19:275–276